# SpectraGenics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spectragenics

- Industry: Consumer Products
- Headquarters: Pleasanton, US
- Website: www.spectragenics.com
- Total disclosed funding: $49M
- Latest round: Series E (Jul 29, 2008)
- Investors on record: 7

## About

SpectraGenics Inc. specializes in providing premium domain assets, primarily focusing on the biotechnology and technology sectors. The company's offerings enhance branding and digital presence for businesses globally.SpectraGenics Inc. operates in the biotechnology and technology sectors, leveraging its premium domain name, spectragenics.com. The company has not undergone any significant pivots in strategy. Headquartered in Pleasanton, US, it was established to cater to startups and established firms seeking to improve their online branding. The company raised USD 30 mn in Series E funding on July 29, 2008, led by Aisling Capital, along with De Novo Ventures, Global Venture Capital, Technology Partners, and Vivo Capital. This round marks the total amount raised by the company, accumulating to USD 30 mn. No information about the founder or CEO is available at this time.SpectraGenics offers the domain name spectragenics.com, a valuable asset for companies in biotechnology, analytics, and technology. Full ownership is provided, including logo design source files and rights of use. The domain allows businesses to create professional email addresses and enhances their marketing and customer engagement. The primary customer base includes startups and established firms in North America, Europe, and Asia.SpectraGenics generates revenue through the sale and lease of its domain name, spectragenics.com. Clients can purchase the domain outright or opt for a lease-to-own arrangement, with the domain transferred to their chosen registrar, such as GoDaddy or NameSilo. The company issues monthly invoices for lease payments, offering early payoff options to facilitate full ownership of the domain.In July 2008, SpectraGenics Inc. secured USD 30 mn in Series E funding to support its growth initiatives. The company plans to enhance its offerings by designing new products aimed at expanding its digital branding solutions. Additionally, SpectraGenics is targeting expansion into North American, European, and Asian markets by leveraging its recent funding to increase market reach and improve service delivery.

## Funding rounds

- Series E, Jul 29, 2008, $30M — Technology Partners, De Novo Ventures, Vivo Capital, Aisling Capital, Global Venture Capital
- Series D, May 24, 2007, $12M — Technology Partners, De Novo Ventures, Global Venture Capital, SDL Ventures, Incubic
- Series C, Jan 3, 2006, $6.3M — Global Venture Capital, SDL Ventures, Incubic

## Investors

- Global Venture Capital (https://capitalatlas.ai/funds/global-venture-capital) — Series C, Series D, Series E
- SDL Ventures (https://capitalatlas.ai/funds/sdl-ventures) — Series C, Series D
- Incubic (https://capitalatlas.ai/funds/incubic) — Series C, Series D
- Technology Partners — Series D, Series E
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series D, Series E
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series E
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series E